Pinkerton P H
Department of Laboratory Medicine, Sunnybrook Health Science Centre, Ontario, Canada.
Transfus Sci. 1996 Jun;17(2):303-8. doi: 10.1016/0955-3886(96)00006-9.
Blood transfusion practices in a Canadian hospital have been compared, as a form of audit, to those reported in a multi-hospital study in Europe, to identify possible deviations from desirable practice. Blood product use for four surgical procedures: laparatomic cholecystectomy, total hip replacement, coronary artery bypass graft (CABG) and abdominal aortic aneurysmectomy (AAA), was determined from this hospital's blood bank data base, and is compared to use for the same procedures in European hospitals. Blood product use here is less than in the majority of European centres, in respect of red cells for all four procedures and plasma for CABG and AAA. Platelet use in association with CABG and AAA is greater than the majority of European centres reporting data. As a consequence, platelet use here will be subjected to closer review.
作为审计的一种形式，一家加拿大医院的输血实践已与欧洲一项多医院研究报告中的输血实践进行了比较，以确定可能偏离理想做法的情况。从该医院血库数据库中确定了四种外科手术（腹腔镜胆囊切除术、全髋关节置换术、冠状动脉搭桥术（CABG）和腹主动脉瘤切除术（AAA））的血液制品使用情况，并与欧洲医院相同手术的使用情况进行了比较。在所有四种手术的红细胞以及CABG和AAA的血浆方面，这里的血液制品使用量低于大多数欧洲中心。与CABG和AAA相关的血小板使用量高于报告数据的大多数欧洲中心。因此，这里的血小板使用情况将受到更密切的审查。
